Banque Pictet & Cie’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-2,878
Closed -$350K 384
2023
Q4
$350K Sell
2,878
-137,599
-98% -$15.4M ﹤0.01% 288
2023
Q3
$15.8M Sell
140,477
-7,865
-5% -$999K 0.19% 63
2023
Q2
$21.6M Sell
148,342
-2,129
-1% -$289K 0.19% 70
2023
Q1
$19.4M Sell
150,471
-6,494
-4% -$815K 0.19% 64
2022
Q4
$20M Buy
156,965
+9,898
+7% +$1.15M 0.21% 66
2022
Q3
$15.4M Buy
147,067
+1,773
+1% +$195K 0.17% 70
2022
Q2
$15.3K Buy
145,294
+2,389
+2% +$283K 0.15% 78
2022
Q1
$18.3M Buy
142,905
+7,999
+6% +$964K 0.14% 84
2021
Q4
$16.6M Buy
134,906
+38,479
+40% +$5.04M 0.12% 93
2021
Q3
$13.7M Sell
96,427
-16
-0% -$2.35K 0.14% 80
2021
Q2
$15.1M Sell
96,443
-992
-1% -$161K 0.17% 81
2021
Q1
$15.1M Sell
97,435
-207
-0.2% -$32.1K 0.19% 76
2020
Q4
$14.6M Sell
97,642
-1,199
-1% -$169K 0.2% 68
2020
Q3
$13.1M Sell
98,841
-731
-0.7% -$95.5K 0.2% 65
2020
Q2
$11.5M Buy
+99,572
New +$11.5M 0.19% 65

Other funds holding ZBH

Banque Pictet & Cie's ZBH Position: Q1 2024 in Review

Banque Pictet & Cie sold out of Zimmer Biomet (ZBH) in Q1 2024, closing a stake of 2,878 shares — an estimated $350K sold.

Banque Pictet & Cie first reported a position in ZBH in Q2 2020 and held it in 15 quarters. The position peaked at $21.6M in Q2 2023. 1,011 funds tracked by Wall St. Rank hold ZBH as of Q1 2024.

  • Banque Pictet & Cie reported no remaining Zimmer Biomet position as of Q1 2024 after selling out during the quarter.
  • Banque Pictet & Cie sold 2,878 Zimmer Biomet shares in Q1 2024, an estimated $350K.
  • Banque Pictet & Cie first reported a position in Zimmer Biomet in Q2 2020 and held it in 15 quarters.
  • Banque Pictet & Cie's Zimmer Biomet position peaked at $21.6M in Q2 2023.
  • 1,011 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2024.

Based on Banque Pictet & Cie's 13F filing for Q1 2024, filed 6 May 2024.